Literature DB >> 7882635

Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

J M Greiff1, D Rowbotham.   

Abstract

Drugs may affect gastrointestinal motility and, therefore, absorption of other concomitantly administered drugs. Gastrointestinal prokinetic agents increase the rate of gastric emptying and also upper intestinal motility. These effects would be expected to increase the initial rate of absorption of orally administered drugs, but reduce total bioavailability of the agents. Metoclopramide has been shown to increase the rate of absorption of several classes of drug, reflected by reduced time taken to achieve maximal plasma concentration (tmax) and increased maximal plasma concentration (Cmax). However, the effect of these agents on the area under the plasma concentration-time curve from zero to infinity (AUC0-infinity), when measured, is not consistent. Cisapride and domperidone appear to have similar effects, but there are relatively less data available regarding these products. Opioids may delay gastric emptying considerably, an effect which will often have significant clinical and therapeutic implications. Most of the data confirming this observation concern oral analgesics, but the effect should be considered when prescribing any oral medication. Drugs with anticholinergic or sympathomimetic activity are likely to have a similar effect and this is confirmed, in the main, by the limited data available. Although many effects reported in the literature are of limited clinical importance, they may be significant when prescribing a drug with a narrow therapeutic index, especially if it is absorbed poorly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7882635     DOI: 10.2165/00003088-199427060-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  72 in total

1.  Inhibition of gastric emptying and drug absorption by narcotic analgesics.

Authors:  W S Nimmo; R C Heading; J Wilson; P Tothill; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

2.  Comparison of the effect of cisapride and metoclopramide on morphine-induced delay in gastric emptying.

Authors:  D J Rowbotham; P A Bamber; W S Nimmo
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

3.  Co-administered oral metoclopramide does not enhance the rate of absorption of oral diazepam.

Authors:  M H Chapman; D F Woolner; E J Begg; H C Atkinson; J R Sharman
Journal:  Anaesth Intensive Care       Date:  1988-05       Impact factor: 1.669

4.  Reversal of narcotic-induced delay in gastric emptying and paracetamol absorption by naloxone.

Authors:  W S Nimmo; R C Heading; J Wilson; L F Prescott
Journal:  Br Med J       Date:  1979-11-10

5.  Propranolol absorption.

Authors:  C F George; M Castleden
Journal:  Br Med J       Date:  1977-01-01

6.  Absorption of antibiotics: influence of metoclopramide and atropine on serum levels of pivampicillin and tetracycline.

Authors:  G Gothoni; P Pentikäinen; H I Vapaatalo; R Hackman; K af Björksten
Journal:  Ann Clin Res       Date:  1972-08

7.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

8.  Modification of oral methotrexate absorption in children with leukemia.

Authors:  M J Mahony; M S Murphy; J Wadsworth; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Kinetics of piretanide absorption from the gastrointestinal tract.

Authors:  D Brockmeier; H G Grigoleit; H Heptner; B H Meyer
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-12

10.  Effect of metoclopramide on gastric emptying before elective and emergency caesarean section.

Authors:  D F Murphy; B Nally; J Gardiner; A Unwin
Journal:  Br J Anaesth       Date:  1984-10       Impact factor: 9.166

View more
  12 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats.

Authors:  Shinichi Watanabe; Katsuya Suemaru; Naoto Inoue; Kimie Imai; Tachio Aimoto; Hiroaki Araki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-01       Impact factor: 3.000

3.  Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions.

Authors:  H Bohets; K Lavrijsen; J Hendrickx; J van Houdt; V van Genechten; P Verboven; W Meuldermans; J Heykants
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Risk Factors, Clinical Presentation, and Outcomes in Overdose With Acetaminophen Alone or With Combination Products: Results From the Acute Liver Failure Study Group.

Authors:  Marina Serper; Michael S Wolf; Nikhil A Parikh; Holly Tillman; William M Lee; Daniel R Ganger
Journal:  J Clin Gastroenterol       Date:  2016-01       Impact factor: 3.062

5.  Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.

Authors:  P H Marathe; Y Wen; J Norton; D S Greene; R H Barbhaiya; I R Wilding
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

6.  Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.

Authors:  Maarten Naesens; Kristin Verbeke; Yves Vanrenterghem; Dirk Kuypers
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

Review 7.  Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndrome.

Authors:  William L Hasler; Philip Schoenfeld
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Aging and intestinal motility: a review of factors that affect intestinal motility in the aged.

Authors:  Denis O'Mahony; Paula O'Leary; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 9.  Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.

Authors:  Lisbeth V Jacobsen; Anne Flint; Anette K Olsen; Steen H Ingwersen
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

Review 10.  Gastrointestinal dysmotility in critically ill patients.

Authors:  Theodoros Ladopoulos; Maria Giannaki; Christina Alexopoulou; Athanasia Proklou; Emmanuel Pediaditis; Eumorfia Kondili
Journal:  Ann Gastroenterol       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.